Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency
- PMID: 7865467
- DOI: 10.1093/intimm/6.11.1739
Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency
Abstract
The immune response of peripheral blood lymphocytes (PBL) of non-exposed human individuals to the Nef protein of HIV-1 was studied. Nef is a regulatory protein of HIV which is immediately expressed after infection and which seems to be important in the pathogenicity of HIV. Nef may therefore serve as a potential target for effective immunity against HIV infection. Epstein-Barr (EBV)-transformed lymphoblastoid B cell lines (LCL) were established from four healthy young seronegative adults and transfected with the Nef gene. These cells served as stimulator cells for autologous PBL in vitro and as target cells for CTL. CTL responses were readily generated against Nef-transfected LCL, consisting of Nef-specific and putative EBV-specific CTL. Nef-specific CTL were generated exclusively from CD8+ cells and were MHC class I restricted. Since a vigorous Nef-specific CTL response in non-infected individuals was unexpected, CTL precursor frequencies were determined by limiting dilution analyses in non-fractionated PBL and in PBL separated into the CD45RO- (naive) and CD45RO+ (memory) T cell populations. As expected, the putative EBV-specific CTL precursors were predominantly found in the CD45RO+ subset at frequencies typical for memory T cells. Nef-specific CTL precursors, in contrast, were found predominantly in the CD45RO- population, at even higher frequencies of approximately 1/1000-1/3000. Nef may thus display either an unusually high number of immunogenic peptides or a limited number of peptides presented in a very efficient way, so that many T cells including low affinity cells, would be triggered.
Similar articles
-
Human immune response to HIV-1 Nef. II. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals.Int Immunol. 1996 Apr;8(4):577-84. doi: 10.1093/intimm/8.4.577. Int Immunol. 1996. PMID: 8671645
-
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.J Exp Med. 1993 Feb 1;177(2):249-56. doi: 10.1084/jem.177.2.249. J Exp Med. 1993. PMID: 8093890 Free PMC article.
-
A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.AIDS Res Hum Retroviruses. 1994 Nov;10(11):1427-31. doi: 10.1089/aid.1994.10.1427. AIDS Res Hum Retroviruses. 1994. PMID: 7888197
-
HIV's evasion of the cellular immune response.Immunol Rev. 1999 Apr;168:65-74. doi: 10.1111/j.1600-065x.1999.tb01283.x. Immunol Rev. 1999. PMID: 10399065 Review.
-
HIV-specific CD8+ T cells: serial killers condemned to die?Curr HIV Res. 2004 Apr;2(2):153-62. doi: 10.2174/1570162043484960. Curr HIV Res. 2004. PMID: 15078179 Review.
Cited by
-
Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.J Virol. 2004 Feb;78(4):1685-96. doi: 10.1128/jvi.78.4.1685-1696.2004. J Virol. 2004. PMID: 14747534 Free PMC article.
-
Design and use of an inducibly activated human immunodeficiency virus type 1 Nef to study immune modulation.J Virol. 2001 Jan;75(2):834-43. doi: 10.1128/JVI.75.2.834-843.2001. J Virol. 2001. PMID: 11134296 Free PMC article.
-
Herpesvirus saimiri-transformed human CD4+ T-cell lines: an efficient target cell system for the analysis of human immunodeficiency virus-specific cytotoxic CD8+ T-lymphocyte activity.J Virol. 1998 Feb;72(2):1627-31. doi: 10.1128/JVI.72.2.1627-1631.1998. J Virol. 1998. PMID: 9445068 Free PMC article.
-
Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.J Virol. 2009 Jan;83(2):940-52. doi: 10.1128/JVI.01520-08. Epub 2008 Oct 29. J Virol. 2009. PMID: 18971264 Free PMC article.
-
HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3.J Exp Med. 1998 Aug 3;188(3):609-14. doi: 10.1084/jem.188.3.609. J Exp Med. 1998. PMID: 9687538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials